Refractory dissecting cellulitis of the scalp treated with adalimumab
Sukhatme, S.V.; Lenzy, Y.M.; Gottlieb, A.B.
Journal of Drugs in Dermatology Jdd 7(10): 981-983
2008
ISSN/ISBN: 1545-9616 PMID: 19112766 Document Number: 14586
Dissecting cellulitis of the scalp (DCS) is a suppurative, neutrophillic dermatosis. Therapies typically provide short-term improvement and include antibiotics, prednisone, and isotretinoin, as well as radiation, surgical excision, and laser ablation. The authors report the use of the tumor necrosis factor (TNF) blocker, adalimumab, to successfully treat a 39-year-old male with a long-standing history of DCS.
Document emailed within 1 workday
